Sammandrag från ERS 27 september – 1 oktober 2025
Vi har samlat de mest spännande insikterna från årets internationella ERS-kongress i Amsterdam, där temat var Respiratory Health around the world.
Var tredje medlem i European Respiratory Society är baserad utanför Europa, vilket gör kongressen till en utmärkt plattform för globalt informationsutbyte. Med årets tema önskar ERS sätta fokus på globala frågor för minska den globala orättvisan inom lunghälsa, och belysa frågar som gagnar lunghälsa för hela jordens befolkning.
Summeringar från ERS 2025
Fighting global threats to respiratory health
Many preventable respiratory hazards are both a cause and a consequence of climate change. Fine particulate matter, especially from wildfires and indoor sources, poses serious health risks and disproportionately affects vulnerable populations. Targeted actions—such as emission reduction, improved indoor air quality, and equity-focused interventions—are essential to protect public health. Läs mer
Act before damage occurs – early disease in COPD
Some get off to a bad start, others never anticipate becoming ill. And others fall into the mind trap of thinking low tobacco exposure could be without harm. Either way, to identify and treat COPD early in disease progression is intriguing – and possible! Läs mer
The exposome and respiratory health: key takeaways from ERS 2025
Lifelong exposure to environmental factors — especially air pollution — significantly affects the risk and progression of chronic lung diseases, and understanding these interactions is key for early intervention and personalized prevention strategies. Läs mer
Improving outcomes in asthma and COPD through optimized inhaler use
Effective inhaler therapy hinges on matching the right device to the right patient—and ensuring proper technique through training. As sustainability goals evolve, clinical decisions must remain patient-centered to avoid unintended harm. Läs mer
Single inhaler triple therapy improved adherence in COPD patients: Evidence from a nationwide Danish cohort study
Poster: Impact of single-inhaler triple therapy on COPD treatment on COPD treatment in the period from 2016-2022: A nationwide Danish cohort study1,2 Clinical practice: Why this mattersFor clinicians, the results Läs mer
Eosinophils in COPD: part of the pattern or misclassified asthma?
Are eosinophils in COPD truly a marker of type 2 (T2) inflammation, or do they simply reflect underlying or misclassified asthma? Läs mer
Role of biological sex in asthma and COPD
Women are more affected by asthma in adulthood and increasingly by COPD. Sex hormones influence immune responses in asthma. Should biological sex guide treatment decisions? Läs mer
Body, mind and spirit: Lung conditions are not just somatic
Mental health is inseparable from physical treatment This was the resounding message from a recent international panel moderated by Dr. Liz Steve, a UK-based health psychologist, at the ERS Congress Läs mer
Patients. Do they know enough to take control?
Do patients with greater knowledge manage their disease better? This question was addressed in a cross sectional study presented at ERS2025. Läs mer
Respiratory health, comorbidities and mortality
Global leading researchers —strongly represented by the Nordics—presented compelling findings on chronic obstructive pulmonary disease (COPD) and its complex interplay with cardiovascular, metabolic, genetic, and socioeconomic factors. Läs mer
Redefining Remission in Severe Asthma: A New Framework
A new framework redefines remission in severe asthma by focusing on disease activity, not damage. Early, targeted treatment during the “at-risk asthma” phase may prevent lasting harm. Läs mer
Could a podcast make – or break – patient engagement in hospital visits?
Podcasts as a tool to support patient participation in hospital consultations: An intervention study Part of the session: Psychological and behavioural dimensions of respiratory innovation Speaker Jannie Frølund (Denmark) In Läs mer
Här hittar du rapporter från tidigare kongresser. Alla sammandrag av föredrag från tidigare ERS-kongresser hittar du längst ned på sidan. Artiklarna är skrivna på engelska.
Tidigare kongressrapporter
Vill du hellre läsa rapporterna som pdf?
ERS 2024
ERS 2023
Äldre rapporter
7386-18.03.2024
Alla artiklar
Could a podcast make – or break – patient engagement in hospital visits?
Podcasts as a tool to support patient participation in hospital consultations: An intervention study Part of the session: Psychological and behavioural dimensions of respiratory innovation Speaker Jannie Frølund (Denmark) In Läs mer
Patients. Do they know enough to take control?
Do patients with greater knowledge manage their disease better? This question was addressed in a cross sectional study presented at ERS2025. Läs mer
Body, mind and spirit: Lung conditions are not just somatic
Mental health is inseparable from physical treatment This was the resounding message from a recent international panel moderated by Dr. Liz Steve, a UK-based health psychologist, at the ERS Congress Läs mer
Respiratory health, comorbidities and mortality
Global leading researchers —strongly represented by the Nordics—presented compelling findings on chronic obstructive pulmonary disease (COPD) and its complex interplay with cardiovascular, metabolic, genetic, and socioeconomic factors. Läs mer
Eosinophils in COPD: part of the pattern or misclassified asthma?
Are eosinophils in COPD truly a marker of type 2 (T2) inflammation, or do they simply reflect underlying or misclassified asthma? Läs mer
Improving outcomes in asthma and COPD through optimized inhaler use
Effective inhaler therapy hinges on matching the right device to the right patient—and ensuring proper technique through training. As sustainability goals evolve, clinical decisions must remain patient-centered to avoid unintended harm. Läs mer
Redefining Remission in Severe Asthma: A New Framework
A new framework redefines remission in severe asthma by focusing on disease activity, not damage. Early, targeted treatment during the “at-risk asthma” phase may prevent lasting harm. Läs mer
Role of biological sex in asthma and COPD
Women are more affected by asthma in adulthood and increasingly by COPD. Sex hormones influence immune responses in asthma. Should biological sex guide treatment decisions? Läs mer
Fighting global threats to respiratory health
Many preventable respiratory hazards are both a cause and a consequence of climate change. Fine particulate matter, especially from wildfires and indoor sources, poses serious health risks and disproportionately affects vulnerable populations. Targeted actions—such as emission reduction, improved indoor air quality, and equity-focused interventions—are essential to protect public health. Läs mer
Act before damage occurs – early disease in COPD
Some get off to a bad start, others never anticipate becoming ill. And others fall into the mind trap of thinking low tobacco exposure could be without harm. Either way, to identify and treat COPD early in disease progression is intriguing - and possible! Läs mer
The exposome and respiratory health: key takeaways from ERS 2025
Lifelong exposure to environmental factors — especially air pollution — significantly affects the risk and progression of chronic lung diseases, and understanding these interactions is key for early intervention and personalized prevention strategies. Läs mer
Single inhaler triple therapy improved adherence in COPD patients: Evidence from a nationwide Danish cohort study
Poster: Impact of single-inhaler triple therapy on COPD treatment on COPD treatment in the period from 2016-2022: A nationwide Danish cohort study1,2 Clinical practice: Why this mattersFor clinicians, the results Läs mer
Are all COPD the same?
Spoiler alert: it is not! You are probably not surprised if you are meeting people living with COPD in health care. But are you aware of the pathophysiological differences behind the different faces of this disease? Läs mer
Self-management of asthma
It is essential to understand the beliefs and decisions that drive behaviour and decision-making around self-management of asthma. What can influence behavior and what does ‘Good Control’ look like for the asthma patient – how can self-management be improved? Läs mer
Consequences of vaping and e-cigarette smoking in children and adolescents
Elif Daglis föreläsning om e-cigaretter väckte ett stort intresse under frågestunden och det är tydligt att vi just nu har fler frågor än svar om långsiktiga risker och vad som kan göras för att stoppa trenden. Läs mer
Lung health starts early
The foetal lungs develop in five different stages before birth, so the timing and type of insults to this development will determine the impact. New data shows that antenatal insults may impact lung function over decades. Läs mer
Preschool wheeze
Preschool wheeze is a heterogenous condition with multiple underlying pathophysiological mechanisms that result in similar clinical manifestations. Frequent severe exacerbations is linked to high risk of developing asthma. Läs mer
Innovating in rehabilitation
Implementation is one of the greatest challenges in pulmonary rehabilitation of COPD. Innovations in rehabilitation may remove barriers to getting onboard a PR programme - and sticking to it. Läs mer
Global burden of COPD
COPD is an increasingly important cause of morbidity, disability and mortality worldwide. Environmental risk factors are important to address for future lung health. Läs mer
Asthma comorbidities
In summary: Asthma is a complex disease worsened by comorbidities like CRSwNP, GERD, OSA, and obesity, which share inflammatory pathways and reduce treatment effectiveness. Obesity, in particular, exacerbates airway inflammation and poor asthma control. A treatable traits approach and multidisciplinary care can improve outcomes by targeting both pulmonary and non-pulmonary factors. Läs mer
Let the music play – music therapy as an adjunct to clinical care
Music therapy options, including music listening and singing may address breathlessness, anxiety and depression to boost psychological well-being and motivation to exercise in people with chronic respiratory disease. Läs mer
What is Pulmonary Rehabilitation?
Professor, Sally Singh from the University of Leicester, UK, delicately presented an overview of the current challenges in pulmonary rehabilitation for breathlessness disorders. Läs mer
Inhaler Technique – Tricky to Master
Correct inhaler technique is tricky but crucial for treatment of asthma and COPD, as you ensure optimal delivery and deposition of the medication when mastering the device used. Läs mer
A whole session on research from a primary care perspective!
Ever wondered about treatable traits of obstructive lung diseases in primary care, the importance of social support for persons living with COPD, or blood eosinophil levels in the general population? Läs mer
Latest insights on COPD and cardiovascular disease
Summary of symposium Clinical year in review - COPD and cardiovascular disease: latest insights in epidemiology, detection and intervention Speakers: Borja Garcia-Cosio, Sami O. Simons, Bianca Beghè & Jennifer Quint. Läs mer
Post-prematurity lung disease: from birth to adulthood
Globally, almost 1 in 10 births are preterm, resulting in 13-15 million preterm babies annually. Thankfully, the survival rates have increased dramatically in the last decades. Läs mer
Towards health equity in 2050
Health equity is a term referring to fair and just opportunity to maintain optimal health. It entails good conditions for leading healthy lives as well as access to care when in need. Läs mer
Smoking in patients with obstructive airway diseases: a challenge beyond COPD
The session focused on the challenges of adolescent smoking, its harmful effects on asthma and COPD patients, and the reduced effectiveness of treatments in smokers. It highlighted that continued smoking accelerates disease progression, while quitting improves symptoms and treatment outcomes. The key message was the critical need for smoking cessation to promote better long-term health. Läs mer
Understanding risk factors of COPD
Förståelsen för riskfaktorer för KOL har tagit stora kliv de senaste 2-3 decennierna. Stämmer det fortfarande att KOL enbart är en sjukdom bland rökare, eller finns det fler påverkningsbara riskfaktorer – andra bränder att släcka? Läs mer
Biologics in COPD – are we there?
Current status of biologics in COPD In Professor Alberto Papi’s comprehensive lecture on the evolving landscape of biological treatment in COPD, he emphasized the proven efficacy of triple therapy in Läs mer
Mild to moderate asthma – mechanisms and phenotyping
Sammanfattning: Astma är en sjukdom där lungfunktionen varierar över tid och mellan individer, mellan normalt och kraftigt nedsatt. Vissa symtom kan hävas med luftförsvidgande medel och andra kräver långvarig antiinflammatorisk Läs mer
Digital biomarkers in asthma management
Trots snabb digitaliseringstakt är digitala biomarkörer för förändringar av astma underutnyttjade. "Wearables", bärbara mätare som smartklockor och fitbits erbjuder möjlighet att erhålla individbaserad högkvalitativ data, men frågan är om digitala biomarkörer kan revolutionera astmabehandling? Läs mer
Digitalisation in health care
Telehälsa omfattar både kliniska och ickekliniska tjänster som använder teknik för sjukvårdsrelaterad information, utbildning, monitorering och stöd. Läs mer
Improving respiratory care from a primary care perspective: Integrated disease management
Sustained health system benefits of primary care based integrated disease management for COPD: an interrupted time series Severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) is a challenge Läs mer
Primary care based integrated COPD disease management – are there benefits for the healthcare system?
Severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) is a challenge for both patient and health care system. Methods to prevent exacerbations are therefore needed. A presentation on Sustained Läs mer
Next generation evidence-based decision-making in respiratory medicine
SUMMARY: A session exploring how real-life research may aid decision-making and guideline development and complement RCT for better assessment of interventions. Bias, both in randomised controlled trials (RCT) and Real-world Läs mer
Longitudinal cohorts in airway disease
Due to the nature of longitudinal studies, the data and learnings obtained are as plenty as they are important and relevant. This became very clear when attending the session covering Läs mer
GOLD guideline evolution: BC is out and Exacerbation prone is in
Reference to presentation: Current challenges in airways disease management – Evolution in GOLD: we cannot ‘see’ ‘C’ anymore and LABA/ICS are gone. Helpful or a hindrance? Speaker: Antonio Anzueto, USA Läs mer
Improving respiratory care from a primary care perspective: International Respiratory Coalition
Last congress morning, a much-changed Milan and ERS appeared: the temperature had dropped, there was light rain, the city smelled of flowers and green grass, and a scarcity of people Läs mer
Burden of tobacco farming and use of electronic nicotine delivery system on the environment and occupational health
SUMMARY: In addition to harmful effects of smoking cigarettes, there are environmental concerns about the complete product life cycle that the tobacco industry is working intensively to downplay. Meanwhile, the Läs mer
A systematic review of methods of scoring inhaler technique
SUMMARY: A systematic review took a look at how inhalation technique has been assessed in research, finding no standardized method to assess, and thereby, compare or rate the quality of Läs mer
Pulmonary rehabilitation in severe and very severe COPD.
SUMMARY: Pulmonary rehabilitation should be tailor made to improve physical and mental conditions to cope with COPD. It improves exercise tolerance, reduces dyspnea and improves quality of life. Despite the Läs mer
Update from the International Respiratory Coalition
Last congress morning, a much-changed Milan and ERS appeared: the temperature had dropped, there was light rain, the city smelled of flowers and green grass, and a scarcity of people Läs mer